| Intensive care outcomes and mortality prediction at a national referral hospital in Western Kenya HS Lalani, W Waweru-Siika, T Mwogi, P Kituyi, JR Egger, LP Park, ... Annals of the American Thoracic Society 15 (11), 1336-1343, 2018 | 59 | 2018 |
| Association of the new peer group–stratified method with the reclassification of penalty status in the Hospital Readmission Reduction Program CP McCarthy, M Vaduganathan, KV Patel, HS Lalani, C Ayers, DL Bhatt, ... JAMA network open 2 (4), e192987-e192987, 2019 | 48 | 2019 |
| US public investment in development of mRNA covid-19 vaccines: retrospective cohort study HS Lalani, S Nagar, A Sarpatwari, RE Barenie, J Avorn, BN Rome, ... bmj 380, 2023 | 44 | 2023 |
| US taxpayers heavily funded the discovery of COVID‐19 vaccines HS Lalani, J Avorn, AS Kesselheim Clinical Pharmacology and Therapeutics 111 (3), 542, 2022 | 30 | 2022 |
| Potential Medicare Part D savings on generic drugs from the Mark Cuban cost Plus drug Company HS Lalani, AS Kesselheim, BN Rome Annals of Internal Medicine 175 (7), 1053-1055, 2022 | 19 | 2022 |
| Trends in utilization and cost of low-density lipoprotein cholesterol–lowering therapies among medicare beneficiaries: an analysis from the medicare part D database A Sumarsono, HS Lalani, M Vaduganathan, AM Navar, GC Fonarow, ... JAMA cardiology 6 (1), 92-96, 2021 | 15 | 2021 |
| Association of Medicaid expansion with rates of utilization of cardiovascular therapies among Medicaid beneficiaries between 2011 and 2018 A Sumarsono, H Lalani, MW Segar, S Rao, M Vaduganathan, ... Circulation: Cardiovascular Quality and Outcomes 14 (1), e007492, 2021 | 14 | 2021 |
| Trends in physician voting practices in California, New York, and Texas, 2006-2018 HS Lalani, DH Johnson, EA Halm, B Maddineni, AS Hong JAMA Internal Medicine 181 (3), 383-385, 2021 | 9 | 2021 |
| Addressing viral medical rumors and false or misleading information HS Lalani, R DiResta, RJ Baron, D Scales Annals of Internal Medicine 176 (8), 1113-1120, 2023 | 8 | 2023 |
| Does an all-condition case management program for high-risk patients reduce health care utilization in medicaid and medicare beneficiaries with diabetes? LP Bui, F Hill-Briggs, N Durkin, A Apfel, PL Ephraim, L Andon, HS Lalani, ... Journal of Diabetes and its Complications 33 (6), 445-450, 2019 | 8 | 2019 |
| Barriers to voting in 2020 among resident physicians HS Lalani, AS Hong, R Siddiqui Journal of general internal medicine 36, 254-255, 2021 | 7 | 2021 |
| Physician knowledge and attitudes toward the adoption of peritoneal dialysis in the treatment of patients with end-stage kidney disease HS Lalani, A Ganguly, LS Brown, J Smartt, DH Johnson, KP Bhavan, ... Cureus 14 (12), 2022 | 6 | 2022 |
| Association of the new peer group-stratified method with the reclassification of penalty status in the Hospital Readmission Reduction Program. JAMA Netw Open. 2019; 2 (4): e192987 CP McCarthy, M Vaduganathan, KV Patel, HS Lalani, C Ayers, DL Bhatt Epub 2019/04/27. doi: https://doi. org/10.1001/jamanetworkopen. 2019.2987 …, 2019 | 5 | 2019 |
| Reply: critical care in sub-saharan africa: is it ready for prime time? HS Lalani, W Waweru-Siika, PS Kussin Annals of the American Thoracic Society 16 (1), 157-158, 2019 | 4 | 2019 |
| Availability and cost of expensive and common generic prescription drugs: a cross-sectional analysis of direct-to-consumer pharmacies HS Lalani, FA Tessema, AS Kesselheim, BN Rome Journal of General Internal Medicine, 1-9, 2024 | 3 | 2024 |
| Get out the vote: a framework to mobilize medical professionals to vote HS Lalani, AS Hong Annals of internal medicine 175 (10), 1476-1478, 2022 | 3 | 2022 |
| Direct-to-consumer generic drugs: a maverick approach or another exposure of market failures? HS Lalani, AS Kesselheim, BN Rome Annals of Internal Medicine 175 (6), 890-891, 2022 | 3 | 2022 |
| Identifying therapeutic alternatives in Medicare drug price negotiation: The case of etanercept H Mooney, M Martin, L Bendicksen, AS Kesselheim, BN Rome, HS Lalani Journal of Managed Care & Specialty Pharmacy 30 (3), 226-233, 2024 | 2 | 2024 |
| The Credibility Conundrum: Can Social Media Companies Define Credibility for Users? HS Lalani, C Laine Annals of Internal Medicine 176 (5), 721-722, 2023 | 2 | 2023 |
| APPROPRIATE LABORATORY EVALUATION IN POST-PITUITARY SURGERY PATIENTS N Lalani, T Kaur, R Karnchanasorn Endocrine Practice 25, 228-229, 2019 | 2 | 2019 |
